Studying the Interactions of U24 from HHV-6 in Order to Further Elucidate Its Potential Role in MS

Viruses. 2022 Oct 28;14(11):2384. doi: 10.3390/v14112384.

Abstract

A number of studies have suggested that human herpesvirus 6A (HHV-6A) may play a role in multiple sclerosis (MS). Three possible hypotheses have been investigated: (1) U24 from HHV-6A (U24-6A) mimics myelin basic protein (MBP) through analogous phosphorylation and interaction with Fyn-SH3; (2) U24-6A affects endocytic recycling by binding human neural precursor cell (NPC) expressed developmentally down-regulated protein 4-like WW3* domain (hNedd4L-WW3*); and (3) MS patients who express Killer Cell Immunoglobulin Like Receptor 2DL2 (KIR2DL2) on natural killer (NK) cells are more susceptible to HHV-6 infection. In this contribution, we examined the validity of these propositions by investigating the interactions of U24 from HHV-6B (U24-6B), a variant less commonly linked to MS, with Fyn-SH3 and hNedd4L-WW3* using heteronuclear single quantum coherence (HSQC) nuclear magnetic resonance (NMR) titrations and isothermal titration calorimetry (ITC). In addition, the importance of phosphorylation and the specific role of U24 in NK cell activation in MS patients were examined. Overall, the findings allowed us to shed light into the models linking HHV-6 to MS and the involvement of U24.

Keywords: Fyn-SH3; Killer Cell Immunoglobulin Like Receptor 2DL2; Nedd4L; Roseolovirus; human herpes virus; multiple sclerosis; natural killer cells; phosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Herpesvirus 6, Human* / physiology
  • Humans
  • Multiple Sclerosis*
  • Nuclear Magnetic Resonance, Biomolecular
  • Phosphorylation
  • Roseolovirus Infections*

Grants and funding

Funding to S.K.S. from the Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-03831) and from the University of British Columbia Faculty of Science (STAIR) are gratefully acknowledged. Funding to R.R. is from the FISM–Fondazione Italiana Sclerosi Multipla onlus grant no° Cod 2019/R-Single/004 and is gratefully acknowledged.